An Evaluation Of PF-03715455 In Moderate To Severe Chronic Obstructive Pulmonary Disease

Status:
Terminated

Trial end date:
2015-05-01

Target enrollment:

Participant gender:

This study proposes to evaluate the safety and efficacy of PF-03715455 in subjects with moderate to severe Chronic Obstructive Pulmonary Disorder.

Phase 2

Pfizer